Calmoseptine, Inc.
Menu
  • External link opens in new tab or window
    • External link opens in new tab or window

Made in the U.S.A.


For the fourth consecutive year, Calmoseptine® Ointment has the distinguished honor of being named

#1 Pharmacist Recommended Brand Incontinence-Related Skin Protectants

by U.S. News & World Report and Pharmacy Times!


We are proud to receive this recognition, and hope that we can continue to serve the community

and promote wound healing throughout the world.


Calmoseptine, Inc. supports charitable causes like the American Red Cross, the World Surgical Foundation, and more.

Click here for more information.

External link opens in new tab or windowPublished Incontinence Associated Dermatitis Clinical Study

External link opens in new tab or window

In this published study, Calmoseptine® Ointment was significantly more effective in healing Incontinence Associated Dermatitis (IAD) than Desitin - 25% in the Calmoseptine group were completely healed at 6 days compared with 7.7% in the Desitin group.

External link opens in new tab or window

External link opens in new tab or windowIncontinence-Associated Dermatitis (IAD) Study:

External link opens in new tab or windowBlind Assessment and Treatment with Zinc Oxide Based Ointment


Population: children >12 years and adults with urinary and/or fecal incontinence and IAD. Following informed consent, participants were randomised to receive a structured skin care regimen for one week with either Calmoseptine® Ointment or Desitin Maximum Strength Diaper Rash Paste.


Results: In the Calmoseptine® Ointment group, significantly higher numbers of participants were completely healed on day 6 (p=0.009) and there were greater reductions in area affected on all follow-up days (p=0.000)


Conclusions: Used within a structured skin care regimen for treatment of IAD, Calmoseptine® Ointment is more effective than Desitin in terms of complete healing and reduction of area affected.

 

External link opens in new tab or windowTreatment of Incontinence Associated Dermatitis in Older Children and Adults on ClinicalTrials.govExternal link opens in new tab or window



A randomized controlled trial that compared the use of two topical zinc oxide based diaper rash products (Calmoseptine vs. Desitin) in a structured care regimen for the treatment of IAD in hospitalized adults and older children.


ClinicalTrials.gov ID NCT02080247

Sponsor University of the Philippines


Calmoseptine, Inc., 16602 Burke Lane, Huntington Beach, CA 92647

Phone : 800-800-3405 | Email: info@calmoseptine.com


close lightbox